These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12555361)

  • 21. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial therapy of hypertension.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1140-2. PubMed ID: 15863559
    [No Abstract]   [Full Text] [Related]  

  • 23. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of blood pressure and endothelin-1 plasma concentration in young, hypertensive patients after treatment with angiotensin converting enzyme inhibitor].
    Bryl W; Miczke A; Bogdański P; Kujawska-Luczak M; Cymerys M; Pupek-Musialik D; Trojnarska O
    Pol Merkur Lekarski; 2005 May; 18(107):524-6. PubMed ID: 16161947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensives.
    Cranwell-Bruce LA
    Medsurg Nurs; 2008 Oct; 17(5):337-41; quiz 342. PubMed ID: 19051983
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
    Ural E; Kozdag G; Kilic T; Ural D; Sahin T; Celebi O; Komsuoglu B
    J Hum Hypertens; 2008 Mar; 22(3):208-10. PubMed ID: 17928875
    [No Abstract]   [Full Text] [Related]  

  • 31. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Esnault VL
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive mechanisms of captopril--a counter-view.
    Lazar AI
    J Assoc Physicians India; 1996 Oct; 44(10):753. PubMed ID: 9251364
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness and tolerance of fosinopril. ACE inhibitor therapy of hypertensive patients in general practice--clinical observation].
    Fassbinder W; Ziegler J
    Fortschr Med; 1997 Dec; 115(34):47-8. PubMed ID: 9465477
    [No Abstract]   [Full Text] [Related]  

  • 39. The multifactorial nature of hypertension: the greatest challenge for its treatment?
    Waeber B; Brunner HR; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Berlipril and Retalzem treatment of hypertension patients: the dynamics of the clinico-hemodynamic indices and of the vasodilating humoral factors].
    Koval' SN; Starchenko TG; Gorb IuG; Pen'kova MIu; Khasanova KhD
    Lik Sprava; 1999; (1):113-7. PubMed ID: 10424019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.